Clariant AG ( (CLZNF) ) has released its Q3 earnings. Here is a breakdown of the information Clariant AG presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clariant AG is a Switzerland-based specialty chemical company focusing on sustainability and innovation, operating through its three business units: Care Chemicals, Catalysts, and Adsorbents & Additives.
In the third quarter of 2025, Clariant reported sales of CHF 906 million, a 3% decrease in local currency terms compared to the same period in 2024, primarily due to lower sales in Care Chemicals and Catalysts, despite modest growth in Adsorbents & Additives. However, the company saw a significant improvement in its EBITDA margin before exceptional items, which rose to 17.9% from 15.6% in the previous year, driven by performance improvement programs and effective price and cost management.
Key financial highlights include a 5% year-on-year increase in Group EBITDA before exceptional items to CHF 162 million, with a corresponding margin improvement of 230 basis points. The company’s Investor Day savings program is on track, contributing CHF 31 million in savings year-to-date. Despite facing currency headwinds and lower volumes, Clariant’s strategic focus on cost efficiency and performance improvements has bolstered its profitability.
Looking ahead, Clariant maintains its 2025 outlook, expecting local currency sales growth at the lower end of the 1-3% range and an EBITDA margin before exceptional items between 17% and 18%. The company remains committed to its medium-term targets, aiming for 4-6% sales growth in local currency and a reported EBITDA margin of 19-21% by 2027.
Overall, Clariant continues to navigate a challenging market environment with resilience, leveraging its strategic initiatives to enhance profitability and sustain growth.